DANILO PANGILINAN: Open Payments
NPI 1184691800 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,037 in 87 payments from 31 companies in 2025. Trend: 2023 $1,660 · 2024 $1,854 · 2025 $2,037
Food & beverage: $2,037
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $325 |
| E.R. Squibb & Sons, L.L.C. | 7 | $214 |
| Sumitomo Pharma America, Inc. | 7 | $169 |
| PFIZER INC. | 8 | $158 |
| Exact Sciences Corporation | 5 | $150 |
| Ardelyx, Inc. | 5 | $128 |
| Novo Nordisk Inc | 5 | $109 |
| ABBVIE INC. | 5 | $105 |
| Merck Sharp & Dohme LLC | 3 | $73 |
| Phathom Pharmaceuticals, Inc. | 2 | $58 |
Products named: ELIQUIS, GEMTESA, IBSRELA, AIRSUPRA, The Cologuard Plus Collection Kit, BEVESPI AEROSPHERE, VRAYLAR, BREZTRI.
Industry payments across CT — which companies pay providers there.
